Researchers in UT Pharmacy's Pharmaceutical Engineering and 3D Printing (PharmE3D) Labs have earned a bevy of national and international awards for their work in pharmaceutical drug delivery and 3D printing personalized medicines.
Read the spring 2022 edition of DiversiTEA Corner, the newsletter about inclusion, diversity, equity and accessibility at the UT College of Pharmacy. This semester’s topics include the college's Dr. Carolyn Brown DEAI Champion Award recipients, a message from Pharmacy Council's DEAI chair, a university three-part series on midwives hosted by UT Pharmacy, our newest member of the DEAI team, and many more.
Pharmacy schools across the country completed their 2022 Phase I and Phase II residency matches for new or upcoming graduates of their Doctor of Pharmacy (Pharm.D.) programs. The University of Texas at Austin College of Pharmacy placed in the top ten of all pharmacy schools in the nation, and number one in Texas.
Dr. Mo Maniruzzaman's Pharmaceutical Engineering and 3D Printing Labs have received a federal grant from the United States Agency for International Development (USAID) to develop personalized 3D printed non-hormonal intrauterine devices (IUDs). The project’s goal is to increase global access to long-term and effective contraception while minimizing some of its most debilitating side effects.
These DEAI Champions have demonstrated exceptional efforts and continue to make significant contributions to creating a more diverse, equitable, accessible and inclusive culture within the college and beyond through their excellent service, teaching, research and/or academic endeavors.
Student pharmacist Cara Rutledge (Pharm.D. Class of 2022) wrote an article for the Pharmacy Times about her honors program thesis which aimed to address the various complexities of student motivation, engagement and attendance in relation to mastery of course material.
UT student pharmacists Kailee Marikar, Sadaf Helforoosh, Hannah McCullough, Agaustin Wong and Cara Rutledge talked to the Pharmacy Times’ Skylar Kenney about their experiences balancing their studies in the midst of the pandemic and how COVID-19 showed a pharmacist's vital role in public health.
The College of Pharmacy’s Pharmaceutical Engineering and 3D Printing (PharmE3D) Labs recently earned a three-year $1.5 million National Institutes of Health (NIH) R01 grant to research novel manufacturing technology for complex vaccine formulations for influenza and other emerging infectious diseases.
The college's Pharmaceutical Engineering and 3D Printing (PharmE3D) labs, led by Assistant Professor in Molecular Pharmaceutics and Drug Delivery Mohammed (Mo) Maniruzzaman, Ph.D., has recently earned several national and international awards and scholarships for outstanding research contributions to the field of pharmaceutical science and technology.
UT Pharmacy and UT Health Science Center San Antonio Assistant Professor Grace C. Lee, Pharm.D., Ph.D. is the first author of a recently published study that unveiled a novel concept, “immunologic resilience,” to accurately predict which COVID-19 patients will advance to severe disease and which will not.